CNX Therapeutics appoints Sarah Morbey as Director of Legal Affairs & ESGNews
We are proud to announce that Sarah Morbey has joined CNX Therapeutics as Director of Legal Affairs & ESG. Sarah is a UK-qualified lawyer and company secretary, with almost 15 years of experience in the healthcare industry. Sarah joins CNX from McKesson where she was Lead Counsel within the MGPSL Business Unit, having previously held roles at Walgreens Boots Alliance and The Francis Crick Institute.
CNX Therapeutics commits to align its operations and strategies to the Ten Principles of the United Nations Global CompactNews
CNX Therapeutics is committed to having a positive impact on society, and we are proud to announce our first key milestone in our mission to take a pioneering approach to ESG; we are now participants to the UN Global Compact, a voluntary leadership platform for the development, implementation and disclosure of responsible business practices.